Terms: = Germ cell tumor AND H3F3A, P84243, H3_3B, MGC87783, MGC87782, H3F3, H3_3A, ENSG00000163041, 3020 AND Treatment
46 results:
1. Antisense oligonucleotide therapy for H3.3K27M diffuse midline glioma.
Zhang Q; Yang L; Liu YH; Wilkinson JE; Krainer AR
Sci Transl Med; 2023 Apr; 15(691):eadd8280. PubMed ID: 37043556
[TBL] [Abstract] [Full Text] [Related]
2. Clinical, histopathological and molecular risk factors for recurrence of pilocytic astrocytomas: brainstem/spinal location, nestin expression and gain of 7q and 19 are associated with early tumor recurrence.
Tamura R; Iwanami A; Ohara K; Nishimoto M; Pareira ES; Miwa T; Tsuzaki N; Kuranari Y; Morimoto Y; Toda M; Okano H; Nakamura M; Yoshida K; Sasaki H
Brain Tumor Pathol; 2023 Apr; 40(2):109-123. PubMed ID: 36892668
[TBL] [Abstract] [Full Text] [Related]
3. Imaging features of localized IDH wild-type histologically diffuse astrocytomas: a single-institution case series.
Kibe Y; Motomura K; Ohka F; Aoki K; Shimizu H; Yamaguchi J; Nishikawa T; Saito R
Sci Rep; 2023 Jan; 13(1):23. PubMed ID: 36646712
[TBL] [Abstract] [Full Text] [Related]
4. [Diffuse midline gliomas with H3K27 alteration in children: a clinicopathological analysis of forty-one cases].
Li J; Ma YY; Feng J; Zhao D; Ding F; Tian L; Chen R; Zhao R
Zhonghua Bing Li Xue Za Zhi; 2022 Apr; 51(4):319-325. PubMed ID: 35359043
[No Abstract] [Full Text] [Related]
5. [Diffuse midline glioma].
Saito R
No Shinkei Geka; 2022 Jan; 50(1):29-38. PubMed ID: 35169084
[TBL] [Abstract] [Full Text] [Related]
6. Targeted therapy with anlotinib for a H3K27M mutation diffuse midline glioma patient with PDGFR-α mutation: a case report.
Wang Q; Niu W; Pan H
Acta Neurochir (Wien); 2022 Aug; 164(8):2063-2066. PubMed ID: 34812950
[TBL] [Abstract] [Full Text] [Related]
7. Pharmaco-proteogenomic profiling of pediatric diffuse midline glioma to inform future treatment strategies.
Findlay IJ; De Iuliis GN; Duchatel RJ; Jackson ER; Vitanza NA; Cain JE; Waszak SM; Dun MD
Oncogene; 2022 Jan; 41(4):461-475. PubMed ID: 34759345
[TBL] [Abstract] [Full Text] [Related]
8. Prognostic and Predictive Biomarkers in Gliomas.
Śledzińska P; Bebyn MG; Furtak J; Kowalewski J; Lewandowska MA
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638714
[TBL] [Abstract] [Full Text] [Related]
9. Gliomas in children and adolescents: investigation of molecular alterations with a potential prognostic and therapeutic impact.
Cabral de Carvalho Corrêa D; Tesser-Gamba F; Dias Oliveira I; Saba da Silva N; Capellano AM; de Seixas Alves MT; Dastoli PA; Cavalheiro S; Caminada de Toledo SR
J Cancer Res Clin Oncol; 2022 Jan; 148(1):107-119. PubMed ID: 34626238
[TBL] [Abstract] [Full Text] [Related]
10. [Intraosseous metastasis of K27-mutant glioma].
Ryzhova MV; Galstyan SA; Starovoitov DV; Snigireva GP; Zubova IV; Golanov AV; Pronin IN; Pavlova GV; Mertsalova MP; Belov AI; Kalinin PL; Serova NK
Arkh Patol; 2021; 83(3):40-44. PubMed ID: 34041895
[TBL] [Abstract] [Full Text] [Related]
11. Model-based evaluation of image-guided fractionated whole-brain radiation therapy in pediatric diffuse intrinsic pontine glioma xenografts.
Husband HR; Campagne O; He C; Zhu X; Bianski BM; Baker SJ; Shelat AA; Tinkle CL; Stewart CF
CPT Pharmacometrics Syst Pharmacol; 2021 Jun; 10(6):599-610. PubMed ID: 33939327
[TBL] [Abstract] [Full Text] [Related]
12. A rare case of adult diffuse midline glioma with H3 K27M mutant in the prepontine cistern.
Chen X; Zhong L; Lin J; Yu J
J Int Med Res; 2021 Jan; 49(1):300060520981266. PubMed ID: 33435779
[TBL] [Abstract] [Full Text] [Related]
13. A pilot radiogenomic study of DIPG reveals distinct subgroups with unique clinical trajectories and therapeutic targets.
Zhu X; Lazow MA; Schafer A; Bartlett A; Senthil Kumar S; Mishra DK; Dexheimer P; DeWire M; Fuller C; Leach JL; Fouladi M; Drissi R
Acta Neuropathol Commun; 2021 Jan; 9(1):14. PubMed ID: 33431066
[TBL] [Abstract] [Full Text] [Related]
14. Evaluation of the melting temperature of TaqMan probes as a genotyping method for IDH1, IDH2, and h3f3a in pediatric astrocytomas.
Torres-Caballero A; Serrato A; López-Santaella T; Ortiz R; León FC; González-Carranza V; Torres-García S; Arenas-Huertero F; Hernández-Hernández A
Bol Med Hosp Infant Mex; 2020; 77(6):303-311. PubMed ID: 33186344
[TBL] [Abstract] [Full Text] [Related]
15. Evaluating h3f3a K27M and G34R/V somatic mutations in a cohort of pediatric brain tumors of different and rare histologies.
Oliveira VF; De Sousa GR; Dos Santos AC; Saggioro FP; Machado HR; de Oliveira RS; Tone LG; Valera ET
Childs Nerv Syst; 2021 Feb; 37(2):375-382. PubMed ID: 32766947
[TBL] [Abstract] [Full Text] [Related]
16. Assessment of circulating tumor DNA in cerebrospinal fluid by whole exome sequencing to detect genomic alterations of glioblastoma.
Duan H; Hu JL; Chen ZH; Li JH; He ZQ; Wang ZN; Zhang GH; Guo XY; Liang L; Mou YG
Chin Med J (Engl); 2020 Jun; 133(12):1415-1421. PubMed ID: 32558704
[TBL] [Abstract] [Full Text] [Related]
17. Improving long-term survival in diffuse intrinsic pontine glioma.
Felker J; Broniscer A
Expert Rev Neurother; 2020 Jul; 20(7):647-658. PubMed ID: 32543245
[TBL] [Abstract] [Full Text] [Related]
18. MR Imaging Correlates for Molecular and Mutational Analyses in Children with Diffuse Intrinsic Pontine Glioma.
Jaimes C; Vajapeyam S; Brown D; Kao PC; Ma C; Greenspan L; Gupta N; Goumnerova L; Bandopahayay P; Dubois F; Greenwald NF; Zack T; Shapira O; Beroukhim R; Ligon KL; Chi S; Kieran MW; Wright KD; Poussaint TY
AJNR Am J Neuroradiol; 2020 May; 41(5):874-881. PubMed ID: 32381545
[TBL] [Abstract] [Full Text] [Related]
19. Targeting Mutant PPM1D Sensitizes Diffuse Intrinsic Pontine Glioma cells to the PARP Inhibitor Olaparib.
Wang Z; Xu C; Diplas BH; Moure CJ; Chen CJ; Chen LH; Du C; Zhu H; Greer PK; Zhang L; He Y; Waitkus MS; Yan H
Mol Cancer Res; 2020 Jul; 18(7):968-980. PubMed ID: 32229503
[TBL] [Abstract] [Full Text] [Related]
20. treatment of Pediatric Glioblastoma with Combination Olaparib and Temozolomide Demonstrates 2-Year Durable Response.
Valiakhmetova A; Gorelyshev S; Konovalov A; Trunin Y; Savateev A; Kram DE; Severson E; Hemmerich A; Edgerly C; Duncan D; Britt N; Huang RSP; Elvin J; Miller V; Ross JS; Gay L; McCorkle J; Rankin A; Erlich RL; Chudnovsky Y; Ramkissoon SH
Oncologist; 2020 Feb; 25(2):e198-e202. PubMed ID: 32043779
[TBL] [Abstract] [Full Text] [Related]
[Next]
